(4-BROMO-2-FLUOROBENZYL)(3-CHLORO-5-FLUOROPHENYL)SULFANE
|
- $437 - $3439
- Product name: (4-BROMO-2-FLUOROBENZYL)(3-CHLORO-5-FLUOROPHENYL)SULFANE
- CAS: 1443314-34-8
- MF: C13H8BrClF2S
- MW: 349.62
- EINECS:
- MDL Number:MFCD18911190
- Synonyms:(4-BROMO-2-FLUOROBENZYL)(3-CHLORO-5-FLUOROPHENYL)SULFANE;Benzene, 4-bromo-1-[[(3-chloro-5-fluorophenyl)thio]methyl]-2-fluoro-
4 prices
Selected condition：
Brand
- Crysdot
Package
- 1g
- 5g
- 10g
- 25g
- ManufacturerCrysdot
- Product numberCD12142768
- Product description(4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97%
- Packaging1g
- Price$437
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12142768
- Product description(4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97%
- Packaging5g
- Price$1177
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12142768
- Product description(4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97%
- Packaging10g
- Price$1882
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12142768
- Product description(4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97%
- Packaging25g
- Price$3439
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD12142768 | (4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97% | 1g | $437 | 2021-12-16 | Buy |
| Crysdot | CD12142768 | (4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97% | 5g | $1177 | 2021-12-16 | Buy |
| Crysdot | CD12142768 | (4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97% | 10g | $1882 | 2021-12-16 | Buy |
| Crysdot | CD12142768 | (4-Bromo-2-fluorobenzyl)(3-chloro-5-fluorophenyl)sulfane 97% | 25g | $3439 | 2021-12-16 | Buy |
Properties
Boiling point :382.1±42.0 °C(Predicted)
Density :1.63±0.1 g/cm3(Predicted)
Density :1.63±0.1 g/cm3(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|